Cargando…
Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review
IMPORTANCE: The economic impact of continuous professional development (CPD) education is incompletely understood. OBJECTIVE: To systematically identify and synthesize published research examining the costs associated with physician CPD for drug prescribing. EVIDENCE REVIEW: MEDLINE, Embase, PsycInf...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792887/ https://www.ncbi.nlm.nih.gov/pubmed/35080604 http://dx.doi.org/10.1001/jamanetworkopen.2021.44973 |
_version_ | 1784640478537318400 |
---|---|
author | Cook, David A. Stephenson, Christopher R. Wilkinson, John M. Maloney, Stephen Foo, Jonathan |
author_facet | Cook, David A. Stephenson, Christopher R. Wilkinson, John M. Maloney, Stephen Foo, Jonathan |
author_sort | Cook, David A. |
collection | PubMed |
description | IMPORTANCE: The economic impact of continuous professional development (CPD) education is incompletely understood. OBJECTIVE: To systematically identify and synthesize published research examining the costs associated with physician CPD for drug prescribing. EVIDENCE REVIEW: MEDLINE, Embase, PsycInfo, and the Cochrane Database were searched from inception to April 23, 2020, for comparative studies that evaluated the cost of CPD focused on drug prescribing. Two reviewers independently screened all articles for inclusion and reviewed all included articles to extract data on participants, educational interventions, study designs, and outcomes (costs and effectiveness). Results were synthesized for educational costs, health care costs, and cost-effectiveness. FINDINGS: Of 3338 articles screened, 38 were included in this analysis. These studies included at least 15 659 health care professionals and 1 963 197 patients. Twelve studies reported on educational costs, ranging from $281 to $183 554 (median, $15 664). When economic outcomes were evaluated, 31 of 33 studies (94%) comparing CPD with no intervention found that CPD was associated with reduced health care costs (drug costs), ranging from $4731 to $6 912 000 (median, $79 373). Four studies found reduced drug costs for 1-on-1 outreach compared with other CPD approaches. Regarding cost-effectiveness, among 5 studies that compared CPD with no intervention, the incremental cost-effectiveness ratio for a 10% improvement in prescribing ranged from $15 390 to $437 027 to train all program participants. Four comparisons of alternative CPD approaches found that 1-on-1 educational outreach was more effective but more expensive than group education or mailed materials (incremental cost-effectiveness ratio, $18-$4105 per physician trained). CONCLUSIONS AND RELEVANCE: In this systematic review, CPD for drug prescribing was associated with reduced health care (drug) costs. The educational costs and cost-effectiveness of CPD varied widely. Several CPD instructional approaches (including educational outreach) were more effective but more costly than comparators. |
format | Online Article Text |
id | pubmed-8792887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-87928872022-02-07 Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review Cook, David A. Stephenson, Christopher R. Wilkinson, John M. Maloney, Stephen Foo, Jonathan JAMA Netw Open Original Investigation IMPORTANCE: The economic impact of continuous professional development (CPD) education is incompletely understood. OBJECTIVE: To systematically identify and synthesize published research examining the costs associated with physician CPD for drug prescribing. EVIDENCE REVIEW: MEDLINE, Embase, PsycInfo, and the Cochrane Database were searched from inception to April 23, 2020, for comparative studies that evaluated the cost of CPD focused on drug prescribing. Two reviewers independently screened all articles for inclusion and reviewed all included articles to extract data on participants, educational interventions, study designs, and outcomes (costs and effectiveness). Results were synthesized for educational costs, health care costs, and cost-effectiveness. FINDINGS: Of 3338 articles screened, 38 were included in this analysis. These studies included at least 15 659 health care professionals and 1 963 197 patients. Twelve studies reported on educational costs, ranging from $281 to $183 554 (median, $15 664). When economic outcomes were evaluated, 31 of 33 studies (94%) comparing CPD with no intervention found that CPD was associated with reduced health care costs (drug costs), ranging from $4731 to $6 912 000 (median, $79 373). Four studies found reduced drug costs for 1-on-1 outreach compared with other CPD approaches. Regarding cost-effectiveness, among 5 studies that compared CPD with no intervention, the incremental cost-effectiveness ratio for a 10% improvement in prescribing ranged from $15 390 to $437 027 to train all program participants. Four comparisons of alternative CPD approaches found that 1-on-1 educational outreach was more effective but more expensive than group education or mailed materials (incremental cost-effectiveness ratio, $18-$4105 per physician trained). CONCLUSIONS AND RELEVANCE: In this systematic review, CPD for drug prescribing was associated with reduced health care (drug) costs. The educational costs and cost-effectiveness of CPD varied widely. Several CPD instructional approaches (including educational outreach) were more effective but more costly than comparators. American Medical Association 2022-01-26 /pmc/articles/PMC8792887/ /pubmed/35080604 http://dx.doi.org/10.1001/jamanetworkopen.2021.44973 Text en Copyright 2022 Cook DA et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Cook, David A. Stephenson, Christopher R. Wilkinson, John M. Maloney, Stephen Foo, Jonathan Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review |
title | Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review |
title_full | Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review |
title_fullStr | Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review |
title_full_unstemmed | Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review |
title_short | Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review |
title_sort | cost-effectiveness and economic benefit of continuous professional development for drug prescribing: a systematic review |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792887/ https://www.ncbi.nlm.nih.gov/pubmed/35080604 http://dx.doi.org/10.1001/jamanetworkopen.2021.44973 |
work_keys_str_mv | AT cookdavida costeffectivenessandeconomicbenefitofcontinuousprofessionaldevelopmentfordrugprescribingasystematicreview AT stephensonchristopherr costeffectivenessandeconomicbenefitofcontinuousprofessionaldevelopmentfordrugprescribingasystematicreview AT wilkinsonjohnm costeffectivenessandeconomicbenefitofcontinuousprofessionaldevelopmentfordrugprescribingasystematicreview AT maloneystephen costeffectivenessandeconomicbenefitofcontinuousprofessionaldevelopmentfordrugprescribingasystematicreview AT foojonathan costeffectivenessandeconomicbenefitofcontinuousprofessionaldevelopmentfordrugprescribingasystematicreview |